NASDAQ
BIOLASE, Inc. (BIOL) has a free cash flow growth of -492.90% as of Friday, May 29, 2026. This represents a 16115.62% decrease compared to its 12-month average of -3.04%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.